

Biography
Dr. Weinacker began her career as a nurse and nurse anesthetist before completing her M.D. at the University of South Alabama College of Medicine, Mobile, in 1986. Her advanced training includes a pulmonary and critical care fellowship and a cardiovascular postdoctoral research fellowship, completed at the University of California, San Francisco in 1994. She is the winner of national honors, editorial posts. Locally, she received the SHC Board of Hospital Director’s coveted Denise O’Leary Award for Clinical Excellence in 2008.
Professional Summary
Education & Certifications
- Fellowship: UCSF Pulmonary and Critical Care Medicine Fellowship (1994) CA
- Residency: University of South Alabama Medical Center Internal Medicine Program (1990) AL
- Medical Education: University of South Alabama College of Medicine Registrar (1986) AL
-
- Board Certification: American Board of Internal Medicine, Critical Care Medicine (1993)
- Board Certification: American Board of Internal Medicine, Internal Medicine (1989)
- M.D., University of South Alabama, Medicine (1986)
- R.N. Anesthetist, University of South Alabama, Anesthesia (1980)
Honors & Awards
- Award for Service to Medical School, University of South Alabama College of Medicine (1986)
- Best Intern Award, University of South Alabama (1987)
- Chief Residents' Teaching Award, Stanford School of Medicine (2003)
-
- Denise O'Leary Award for Clinical Excellence, Stanford Hospital and Clinics Board of Directors (2008)
- Excellence in Teaching, Stanford University School of Medicine (2004)
- Honor Medical Society, Alpha Omega Alpha (2006)
- Leadership Development in Pulmonary & Critical Care Medicine, American College of Chest Physicians (1999)
- Victor Benator Award for Best Teaching Resident, University of South Alabama (1989)
Memberships
- Member, Society of Critical Care Medicine (2000 - Present)
- Member, American Thoracic Society (1990 - Present)
- Fellow, American College of Chest Physicians (1990 - Present)
-
Administrative Appointments
- Associate Chief Medical Officer, Patient Care Services, Stanford Health Care (2016 - Present)
- Associate Director, Intensive Care Unit, Stanford University Medical Center (1999 - 2020)
- Chair, Emergency Medical Response Team Committee, Stanford University Medical Center (2007 - 2011)
-
- Chair, Rapid Response Team Committee, Stanford University Medical Center (2005 - 2007)
- Chief of Staff, Stanford Hospital and Clinics (2011 - 2014)
- Chief Physician Executive, The Risk Authority at Stanford Medicine (2019 - Present)
- Continuing Quality Improvement in the ICU Committee, Stanford University School of Medicine (2003 - Present)
- Credentials Committee, American College of Chest Physicians (2000 - 2004)
- Dean's Task Force for Clinical Excellence, Stanford University School of Medicine (2007 - 2008)
- Fellowship Director, Critical Care Medicine, Department of Medicine, Stanford University (2014 - 2017)
- Fellowship Director, Pulmonary & Critical Care Medicine, Department of Medicine, Stanford University (2001 - 2002)
- Immediate Past Chief of Staff, Stanford Health Care (2014 - 2017)
- Interim Chief Quality Officer, Stanford Health Care (2017 - 2018)
- Interim Director, Heart-Lung and Lung Transplant Program, Stanford University School of Medicine (2005 - 2006)
- Medical Director, Intensive Care Units, Stanford Health Care (2020 - Present)
- Quality Improvement & Patient Safety Committee, Stanford University Medical Center (2007 - Present)
- Senior Vice Chair of Medicine for Clinical Affairs, Stanford University (2017 - Present)
- Vice Chair, Clinical Affairs, Department of Medicine, Stanford University (2007 - 2008)
- Vice Chair, Quality -- Implementation, Department of Medicine, Stanford University (2014 - 2017)
- Vice Chief of Staff, Stanford Hospital and Clinics (2010 - 2011)
Publications
-
beta-adrenergic-blocking agents in bronchospastic diseases: A therapeutic dilemma
Tafreshi, M. J., & Weinacker, A. B. (1999). beta-adrenergic-blocking agents in bronchospastic diseases: A therapeutic dilemma. PHARMACOTHERAPY, 19(8), 974–978. -
Quality of life and lung volume reduction surgery.
Faul, J. L., Doyle, R. L., Weinacker, A. B., & Raffin, T. A. (1999). Quality of life and lung volume reduction surgery. American Journal of Critical Care , 8(6), 359–360. -
Inhalational anthrax - Epidemiology, diagnosis, and management
Shafazand, S., Doyle, R., Ruoss, S., Weinacker, A., & Raffin, T. A. (1999). Inhalational anthrax - Epidemiology, diagnosis, and management. CHEST, 116(5), 1369–76. -
-
The patient's response to medical futility
McGee, D. C., Weinacker, A. B., & Raffin, T. A. (2000). The patient's response to medical futility. ARCHIVES OF INTERNAL MEDICINE, 160(11), 1565–1566. -
Withdrawing life support from the critically ill
McGee, D. C., Weinacker, A. B., & Raffin, T. A. (2000). Withdrawing life support from the critically ill. CHEST, 118(5), 1238–1239. -
A brave new world: Remote intensive care unit care for the 21st century
Shafazand, S., Shigemitsu, H., & Weinacker, A. B. (2000). A brave new world: Remote intensive care unit care for the 21st century. CRITICAL CARE MEDICINE, 28(12), 3945–3946. -
Acute respiratory distress syndrome: Physiology and new management strategies
Weinacker, A. B., & Vaszar, L. T. (2001). Acute respiratory distress syndrome: Physiology and new management strategies. ANNUAL REVIEW OF MEDICINE, 52, 221–37. -
Diagnostic yield of screening colonoscopies in lung transplant candidates
Singer, L. G., Weinacker, A. B., Levin, L., Doyle, R. L., & Theodore, J. (2001). Diagnostic yield of screening colonoscopies in lung transplant candidates. TRANSPLANTATION, 72(3), 530–32. -
A cystic upper lobe lesion in a healthy nonsmoking man - Angiosarcoma of the left upper lobe, presumed metastatic
Leonard, C. T., Weinacker, A., Berry, G., & Whyte, R. I. (2001). A cystic upper lobe lesion in a healthy nonsmoking man - Angiosarcoma of the left upper lobe, presumed metastatic. CHEST, 120(5), 1725–27. -
Nodular invasive tracheobronchitis due to Aspergillus in a patient with systemic lupus erythematosus
Angelotti, T., Krishna, G., Scott, J., Berry, G., & Weinacker, A. (2002). Nodular invasive tracheobronchitis due to Aspergillus in a patient with systemic lupus erythematosus. LUPUS, 11(5), 325–28. -
Blood cultures in the critical care unit - Improving utilization and yield
Shafazand, S., & Weinacker, A. B. (2002). Blood cultures in the critical care unit - Improving utilization and yield. CHEST, 122(5), 1727–36. -
Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia
Fowler, R. A., Flavin, K. E., Barr, J., Weinacker, A. B., Parsonnet, J., & Gould, M. K. (2003). Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. CHEST, 123(3), 835–44. -
Intensive care unit support of hematopoietic stem cell transplant recipients: A case for cautious optimism
Weinacker, A. (2003). Intensive care unit support of hematopoietic stem cell transplant recipients: A case for cautious optimism. CRITICAL CARE MEDICINE, 31(6), 1873–1875. -
The value of preoperative pulmonary rehabilitation.
Takaoka, S. T., & Weinacker, A. B. (2005). The value of preoperative pulmonary rehabilitation. Thoracic Surgery Clinics, 15(2), 203–11. -
Ethical issues in the long term management of progressive degenerative neuromuscular diseases
Vaszar, L. T., Weinacker, A. B., Henig, N. R., & Raffin, T. A. (2002). Ethical issues in the long term management of progressive degenerative neuromuscular diseases. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 23(3), 307–14. -
Smoking in contemporary American cinema
Omidvari, K., Lessnau, K., Kim, J., Mercante, D., Weinacker, A., & Mason, C. (2005). Smoking in contemporary American cinema. CHEST, 128(2), 746–54. -
Smoking in movies
Glantz, S. A., & Polansky, J. (2006). Smoking in movies. CHEST, 129(2), 495–495. -
Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction
Christie, J. D., Robinson, N., Ware, L. B., Plotnick, M., De Andrade, J., Lama, V., … Kawut, S. M. (2007). Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 175(1), 69–74. -
Management strategies for patients with pulmonary hypertension in the intensive care unit
Zamanian, R. T., Haddad, F., Doyle, R. L., & Weinacker, A. B. (2007). Management strategies for patients with pulmonary hypertension in the intensive care unit. CRITICAL CARE MEDICINE, 35(9), 2037–50. -
Plasma intercellular adhesion molecule-1 and von willebrand factor in primary graft dysfunction after lung transplantation
Covarrubias, M., Ware, L. B., Kawut, S. M., de Andrade, J., Milstone, A., Weinacker, A., … Christie, J. D. (2007). Plasma intercellular adhesion molecule-1 and von willebrand factor in primary graft dysfunction after lung transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 7(11), 2573–2578. -
Randomized clinical trial of activated protein C for the treatment of acute lung injury
Liu, K. D., Levitt, J., Zhuo, H., Kallet, R. H., Brady, S., Steingrub, J., … Matthay, M. A. (2008). Randomized clinical trial of activated protein C for the treatment of acute lung injury. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 178(6), 618–23. -
Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation
Hoffman, S. A., Wang, L., Shah, C. V., Ahya, V. N., Pochettino, A., Olthoff, K., … Christie, J. D. (2009). Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 9(2), 389–396. -
Soluble P-Selectin and the Risk of Primary Graft Dysfunction After Lung Transplantation
Kawut, S. M., Okun, J., Shimbo, D., Lederer, D. J., De Andrade, J., Lama, V., … Christie, J. D. (2009). Soluble P-Selectin and the Risk of Primary Graft Dysfunction After Lung Transplantation. CHEST, 136(1), 237–44. -
Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction
Christie, J. D., Shah, C. V., Kawut, S. M., Mangalmurti, N., Lederer, D. J., Sonett, J. R., … Ware, L. B. (2009). Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 180(10), 1010–15. -
Construct validity of the definition of primary graft dysfunction after lung transplantation
Christie, J. D., Bellamy, S., Ware, L. B., Lederer, D., Hadjiliadis, D., Lee, J., … Kawut, S. M. (2010). Construct validity of the definition of primary graft dysfunction after lung transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(11), 1231–39. -
Elevated Pulmonary Artery Pressure Is a Risk Factor for Primary Graft Dysfunction Following Lung Transplantation for Idiopathic Pulmonary Fibrosis
Fang, A., Studer, S., Kawut, S. M., Ahya, V. N., Lee, J., Wille, K., … Christie, J. D. (2011). Elevated Pulmonary Artery Pressure Is a Risk Factor for Primary Graft Dysfunction Following Lung Transplantation for Idiopathic Pulmonary Fibrosis. CHEST, 139(4), 782–87. -
Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High-Grade Primary Graft Dysfunction
Diamond, J. M., Kawut, S. M., Lederer, D. J., Ahya, V. N., Kohl, B., Sonett, J., … Ware, L. B. (2011). Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High-Grade Primary Graft Dysfunction. AMERICAN JOURNAL OF TRANSPLANTATION, 11(3), 561–567. -
Effect of Single vs Bilateral Lung Transplantation on Plasma Surfactant Protein D Levels in Idiopathic Pulmonary Fibrosis
Sims, M. W., Beers, M. F., Ahya, V. N., Kawut, S. M., Sims, K. D., Lederer, D. J., … Ware, L. B. (2011). Effect of Single vs Bilateral Lung Transplantation on Plasma Surfactant Protein D Levels in Idiopathic Pulmonary Fibrosis. CHEST, 140(2), 489–96. -
Obesity and Primary Graft Dysfunction after Lung Transplantation The Lung Transplant Outcomes Group Obesity Study
Lederer, D. J., Kawut, S. M., Wickersham, N., Winterbottom, C., Bhorade, S., Palmer, S. M., … Christie, J. D. (2011). Obesity and Primary Graft Dysfunction after Lung Transplantation The Lung Transplant Outcomes Group Obesity Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 184(9), 1055–61. -
Elevated Plasma Long Pentraxin-3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis
Diamond, J. M., Lederer, D. J., Kawut, S. M., Lee, J., Ahya, V. N., Bellamy, S., … Christie, J. D. (2011). Elevated Plasma Long Pentraxin-3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF TRANSPLANTATION, 11(11), 2517–22. -
High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: Results of the QT in Practice (QTIP) Study
Pickham, D., Helfenbein, E., Shinn, J. A., Chan, G., Funk, M., Weinacker, A., … Drew, B. J. (2012). High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: Results of the QT in Practice (QTIP) Study. CRITICAL CARE MEDICINE, 40(2), 394–99. -
The "Slow Code" Should Be a "No Code"
Weinacker, A. (2011). The "Slow Code" Should Be a "No Code". AMERICAN JOURNAL OF BIOETHICS, 11(11), 27–29. -
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation
Shah, R. J., Bellamy, S. L., Localio, A. R., Wickersham, N., Diamond, J. M., Weinacker, A., … Christie, J. D. (2012). A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 31(9), 942–49. -
Variation in PTX3 Is Associated with Primary Graft Dysfunction after Lung Transplantation
Diamond, J. M., Meyer, N. J., Feng, R., Rushefski, M., Lederer, D. J., Kawut, S. M., … Christie, J. D. (2012). Variation in PTX3 Is Associated with Primary Graft Dysfunction after Lung Transplantation. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 186(6), 546–52. -
Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation
Diamond, J. M., Porteous, M. K., Cantu, E., Meyer, N. J., Shah, R. J., Lederer, D. J., … Christie, J. D. (2012). Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation. PLOS ONE, 7(12). -
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., … Christie, J. D. (2013). Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 187(5), 527–34. -
Still a man's world, but why?
Weinacker, A., & Stapleton, R. D. (2013). Still a man's world, but why? Critical Care (London, England), 17(1), 113. -
Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.
Shah, R. J., Diamond, J. M., Cantu, E., Lee, J. C., Lederer, D. J., Lama, V. N., … Christie, J. D. (2013). Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest, 144(2), 616–22. -
DISTRIBUTION OF INTEGRINS ALPHA-V-BETA-6 AND ALPHA-9-BETA-1 AND THEIR KNOWN LIGANDS, FIBRONECTIN AND TENASCIN, IN HUMAN AIRWAYS
Weinacker, A., Ferrando, R., Elliott, M., Hogg, J., Balmes, J., & Sheppard, D. (1995). DISTRIBUTION OF INTEGRINS ALPHA-V-BETA-6 AND ALPHA-9-BETA-1 AND THEIR KNOWN LIGANDS, FIBRONECTIN AND TENASCIN, IN HUMAN AIRWAYS. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 12(5), 547–556. -
EFFECTS OF BETA-SUBUNIT CYTOPLASMIC DOMAIN DELETIONS ON THE RECRUITMENT OF THE INTEGRIN ALPHA-NU-BETA-6 TO FOCAL CONTACTS
CONE, R. I., Weinacker, A., Chen, A., & Sheppard, D. (1994). EFFECTS OF BETA-SUBUNIT CYTOPLASMIC DOMAIN DELETIONS ON THE RECRUITMENT OF THE INTEGRIN ALPHA-NU-BETA-6 TO FOCAL CONTACTS. CELL ADHESION AND COMMUNICATION, 2(2), 101–113. -
ROLE OF THE INTEGRIN ALPHA-V-BETA-6 IN CELL ATTACHMENT TO FIBRONECTIN - HETEROLOGOUS EXPRESSION OF INTACT AND SECRETED FORMS OF THE RECEPTOR
Weinacker, A., Chen, A., Agrez, M., CONE, R. I., Nishimura, S., Wayner, E., … Sheppard, D. (1994). ROLE OF THE INTEGRIN ALPHA-V-BETA-6 IN CELL ATTACHMENT TO FIBRONECTIN - HETEROLOGOUS EXPRESSION OF INTACT AND SECRETED FORMS OF THE RECEPTOR. JOURNAL OF BIOLOGICAL CHEMISTRY, 269(9), 6940–6948. -
UPPER AND MIDDLE LOBE BRONCHOALVEOLAR LAVAGE TO DIAGNOSE PNEUMOCYSTIS-CARINII PNEUMONIA
Yung, R. C., Weinacker, A. B., Steiger, D. J., Miller, T. R., Stern, E. J., SALMON, C. J., … Golden, J. A. (1993). UPPER AND MIDDLE LOBE BRONCHOALVEOLAR LAVAGE TO DIAGNOSE PNEUMOCYSTIS-CARINII PNEUMONIA. AMERICAN REVIEW OF RESPIRATORY DISEASE, 148(6), 1563–1566. -
IDIOPATHIC GIANT BULLOUS EMPHYSEMA (VANISHING LUNG SYNDROME) - IMAGING FINDINGS IN 9 PATIENTS
Stern, E. J., Webb, W. R., Weinacker, A., & Muller, N. L. (1994). IDIOPATHIC GIANT BULLOUS EMPHYSEMA (VANISHING LUNG SYNDROME) - IMAGING FINDINGS IN 9 PATIENTS. AMERICAN JOURNAL OF ROENTGENOLOGY, 162(2), 279–282. -
Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
Schwarzenberger, P., Harrison, L., Weinacker, A., Gaumer, R., Theodossiou, C., Summer, W., … Kolls, J. (1998). Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana. Journal of the Louisiana State Medical Society , 150(4), 168–174. -
Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma
Schwarzenberger, P., Lei, D. H., Freeman, S. M., Ye, P., Weinacker, A., Theodossiou, C., … Kolls, J. K. (1998). Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 19(2), 333–337. -
The treatment of malignant mesothelioma with a gene modified cancer cell line: A phase I study
Schwarzenberger, P., Harrison, L., Weinacker, A., Marrogi, A., Byrne, P., Ramesh, R., … Kolls, J. K. (1998). The treatment of malignant mesothelioma with a gene modified cancer cell line: A phase I study. HUMAN GENE THERAPY, 9(17), 2641–2649. -
Systematic reviews and evidence-based critical care medicine: A step in the right direction
Gould, M. K., Leonard, C. T., Weinacker, A. B., & Raffin, T. A. (1998). Systematic reviews and evidence-based critical care medicine: A step in the right direction. AMERICAN JOURNAL OF MEDICINE, 105(6), 551–553. -
High dose cyclophosphamide efficacy in a patient with refractory anti-MuSK positive myasthenia gravis
High dose cyclophosphamide efficacy in a patient with refractory anti-MuSK positive myasthenia gravis. (2006). Muscle & Nerve, 33. -
Lung transplantation: A decade of experience
Lung transplantation: A decade of experience. (2005). J Heart Lung Transplant, 24. -
PTX3 Polymorphisms Are Associated with Primary Graft Dysfunction after Lung Transplantation
Diamond, J. M., Feng, R., Meyer, N., Lederer, D., Lee, J., Kawut, S., … Christie, J. D. (2011). PTX3 Polymorphisms Are Associated with Primary Graft Dysfunction after Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(4), S23–S23. -
A Panel of Lung Injury Biomarkers Enhances the Definition of Primary Graft Dysfunction (PGD) after Lung Transplantation for Early Clinical Studies
Shah, R. J., Diamond, J. M., Kawut, S. M., Lee, J. C., Lederer, D. J., Bhorade, S., … Christie, J. D. (2012). A Panel of Lung Injury Biomarkers Enhances the Definition of Primary Graft Dysfunction (PGD) after Lung Transplantation for Early Clinical Studies. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 31(4), S103–S103. -
Functional TLR4 Polymorphisms Are Associated with Lower Risk of Primary Graft Dysfunction (PGD) after Lung Transplantation
Diamond, J. M., Feng, R., Meyer, N. J., Shah, R., Kawut, S. M., Lederer, D. J., … Christie, J. D. (2012). Functional TLR4 Polymorphisms Are Associated with Lower Risk of Primary Graft Dysfunction (PGD) after Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 31(4), S78–S78. -
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., … Christie, J. D. (2013). Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 32(4), S43–S43. -
Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk
Cantu, E., Suzuki, Y., Diamond, J. M., Shah, R. J., Flesch, J. D., Meyer, N. J., … Christie, J. D. (2013). Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 32(4), S29–S29. -
A program for the use of handheld echocardiography by intensivists to augment physical exam assessment
Liang, D. H., Thompson, N., Lin, J. H., Rubaii, J., & Weinacker, A. (2003). A program for the use of handheld echocardiography by intensivists to augment physical exam assessment. CRITICAL CARE MEDICINE. ORLANDO,FL,FL: LIPPINCOTT WILLIAMS & WILKINS. -
Plasma Levels of Receptor for Advanced Glycation End-Products (RAGE) Are Associated with Primary Graft Dysfunction
Christie, J. D., Shah, C. V., Kawut, S., Sonnett, J., Abya, V. N., Wille, K., … Ware, L. B. (2009). Plasma Levels of Receptor for Advanced Glycation End-Products (RAGE) Are Associated with Primary Graft Dysfunction. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(2), S308–S309. -
Clinical risk factors for the development of primary graft dysfunction
Lee, J. C., Kuntz, C., Kawut, S. M., Hadjiliadis, D., Abya, V. N., Wille, K. M., … Christie, J. D. (2008). Clinical risk factors for the development of primary graft dysfunction. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 27(2), S67–S68. -
Temporal Trends in the Prevalence of Primary Graft Dysfunction after Lung Transplantation in the Lung Transplant Outcomes Group (LTOG) Cohort
Robbins, H. Y., Arcasoy, S. M., Bhorade, S., Crespo, M. M., Kawut, S. M., Lama, V. N., … Lederer, D. J. (2011). Temporal Trends in the Prevalence of Primary Graft Dysfunction after Lung Transplantation in the Lung Transplant Outcomes Group (LTOG) Cohort. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(4), S22–S23. -
Lung Size Mismatch and Primary Graft Dysfunction after Bilateral Lung Transplantation
Eberlein, M., Reed, R. M., Bolukbas, S., Orens, J. B., Brower, R. G., Merlo, C. A., … Christie, J. D. (2013). Lung Size Mismatch and Primary Graft Dysfunction after Bilateral Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 32(4), S41–S41. -
Cytokine and chemokine profiles in primary graft dysfunction following lung transplantation.
Hoffman, S. A., Wang, L., Ahya, V. N., Pochettino, A., Olthoff, K., Shaked, A., … Christie, J. D. (2007). Cytokine and chemokine profiles in primary graft dysfunction following lung transplantation. Presented at the 7th American Transplant Congress, SAN FRANCISCO,CA,CA,CA,CA: WILEY-BLACKWELL. -
Preoperative Plasma Club (Clara) Cell Secretory Protein Levels Are Associated With Primary Graft Dysfunction After Lung Transplantation
Shah, R. J., Wickersham, N., Lederer, D. J., Palmer, S. M., Cantu, E., Diamond, J. M., … Ware, L. B. (2014). Preoperative Plasma Club (Clara) Cell Secretory Protein Levels Are Associated With Primary Graft Dysfunction After Lung Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 14(2), 446–52. -
Genetic Variation in the Prostaglandin E-2 Pathway Is Associated with Primary Graft Dysfunction
Diamond, J. M., Akimova, T., Kazi, A., Shah, R. J., Cantu, E., Feng, R., … Christie, J. D. (2014). Genetic Variation in the Prostaglandin E-2 Pathway Is Associated with Primary Graft Dysfunction. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 189(5), 567–75. -
Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation
Shah, R. J., Diamond, J. M., Cantu, E., Flesch, J., Lee, J. C., Lederer, D. J., … Christie, J. D. (2015). Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 15(8), 2188–96. -
Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.
Cantu, E., Suzuki, Y., Diamond, J. M., Ellis, J., Tiwari, J., Beduhn, B., … Christie, J. D. (2016). Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. American Journal of Transplantation , 16(3), 833–40. -
The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
Diamond, J. M., Porteous, M. K., Jackson Roberts, L., Wickersham, N., Rushefski, M., Kawut, S. M., … Christie, J. D. (2016). The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. Journal of Heart and Lung Transplantation , 35(4), 500–507. -
A Multidisciplinary Initiative to Increase Inpatient Discharges Before Noon
Kane, M., Weinacker, A., Arthofer, R., Seay-Morrison, T., Elfman, W., Ramirez, M., … Welton, M. (2016). A Multidisciplinary Initiative to Increase Inpatient Discharges Before Noon. JOURNAL OF NURSING ADMINISTRATION, 46(12), 630–35. -
Lean-Based Redesign of Multidisciplinary Rounds on General Medicine Service.
Kane, M., Rohatgi, N., Heidenreich, P., Thakur, A., Winget, M., Shum, K., … Ahuja, N. (2018). Lean-Based Redesign of Multidisciplinary Rounds on General Medicine Service. Journal of Hospital Medicine. -
Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury
Shaver, C. M., Wickersham, N., McNeil, J. B., Nagata, H., Miller, A., Landstreet, S. R., … Ware, L. B. (2018). Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury. JCI INSIGHT, 3(2). -
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant
Cantu, E., Diamond, J. M., Suzuki, Y., Lasky, J., Schaufler, C., Lim, B., … Christie, J. D. (2018). Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197(2), 235–43. -
Explanatory Model For Primary Graft Dysfunction Among Patients With Pulmonary Hypertension
Porteous, M., Lederer, D. J., Palmer, S. M., Cantu, E., Shah, R. J., Bellamy, S. L., … Diamond, J. M. (2015). Explanatory Model For Primary Graft Dysfunction Among Patients With Pulmonary Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC. -
Candidate Gene Association Study in BOS
Diamond, J. M., Feng, R., Lin, W., Shah, R., Cantu, E., Demissie, E., … Christie, J. (2014). Candidate Gene Association Study in BOS. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Soluble CD14 and LBP as Markers for Primary Graft Dysfunction
Ramphal, K., Cantu, E., Porteous, M., Oyster, M., Kawut, S., Lederer, D. J., … Diamond, J. (2016). Soluble CD14 and LBP as Markers for Primary Graft Dysfunction. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Plasma RIP3 Is Decreased in PGD after Lung Transplantation
D'Errico, C., Hotz, M., Cantu, E., Porteous, M., Oyster, M., Shah, R., … Diamond, J. M. (2016). Plasma RIP3 Is Decreased in PGD after Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Redefining Primary Graft Dysfunction after Lung Transplantation
Cantu, E., Diamond, J., Nellen, J., Beduhn, B., Suzuki, Y., Borders, C., … Christie, J. D. (2016). Redefining Primary Graft Dysfunction after Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Use Of A Simple Prediction Model Improves Pre-Transplant Risk Stratification For Primary Graft Dysfunction After Lung Transplantation
Shah, R. J., Diamond, J. M., Cantu, E., Localio, A. R., Bellamy, S., Flesch, J., … Christie, J. D. (2013). Use Of A Simple Prediction Model Improves Pre-Transplant Risk Stratification For Primary Graft Dysfunction After Lung Transplantation. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC. -
Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking
Ware, L. B., Roberts, L. J., Diamond, J. M., Wickersham, N., Palmer, S. M., Lederer, D., … Christie, J. D. (2014). Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Clinical Prediction Model for PGD Among Patients With Pulmonary Hypertension
Porteous, M., Lederer, D. J., Palmer, S. M., Cantu, E., Shah, R. J., Bellamny, S., … Diamond, J. M. (2015). Clinical Prediction Model for PGD Among Patients With Pulmonary Hypertension. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Patterns of Disrespectful Physician Behavior at an Academic Medical Center: Implications for Training, Prevention, and Remediation.
Hopkins, J., Hedlin, H., Weinacker, A., & Desai, M. (2018). Patterns of Disrespectful Physician Behavior at an Academic Medical Center: Implications for Training, Prevention, and Remediation. Academic Medicine : Journal of the Association of American Medical Colleges. -
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension
Porteous, M. K., Lee, J. C., Lederer, D. J., Palmer, S. M., Cantu, E., Shah, R. J., … Diamond, J. M. (2017). Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. ANNALS OF THE AMERICAN THORACIC SOCIETY, 14(10), 1514–22. -
Risk Factors for Primary Graft Dysfunction in Patients with Cystic Fibrosis Receiving Lung Transplants
Martin, J. A., Porteous, M. K., Cantu, E., Lederer, D. J., Snyder, L., Weinacker, A., … Diamond, J. M. (2019). Risk Factors for Primary Graft Dysfunction in Patients with Cystic Fibrosis Receiving Lung Transplants. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 38(4), S147. -
Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation.
Shah, R. J., Diamond, J. M., Cantu, E., Flesch, J., Lee, J. C., Lederer, D. J., … Christie, J. D. (2015). Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 15(8), 2188–96. -
Hospital Length of Stay Following Lung Transplantation for Connective Tissue Disease-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
Natalini, J. G., Porteous, M., Lederer, D. J., Wille, K. M., Weinacker, A. B., Orens, J. B., … Kawut, S. M. (2019). Hospital Length of Stay Following Lung Transplantation for Connective Tissue Disease-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 199. -
Lean-Based Redesign of Multidisciplinary Rounds on General Medicine Service
Kane, M., Rohatgi, N., Heidenreich, P. A., Thakur, A., Winget, M., Shum, K., … Ahuja, N. (2018). Lean-Based Redesign of Multidisciplinary Rounds on General Medicine Service. JOURNAL OF HOSPITAL MEDICINE, 13(7), 482–85. -
Characteristics of Academic Physicians Associated With Patient Satisfaction
Heidenreich, P., Shieh, L., Fassiotto, M., Kahn, J., Weinacker, A., Smith, R., … Palaniappan, L. (2019). Characteristics of Academic Physicians Associated With Patient Satisfaction. AMERICAN JOURNAL OF MEDICAL QUALITY, 1062860619876344. -
Implications of ECMO Bridging and Salvage Strategies on Mortality and PGD
Cantu, E., Bermudez, C., Cevasco, M., Suzuki, Y., Buckley, T., Galati, V., … Christie, J. (2020). Implications of ECMO Bridging and Salvage Strategies on Mortality and PGD. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 39(4), S103–S104. -
Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
Natalini, J. G., Diamond, J. M., Porteous, M. K., Lederer, D. J., Wille, K. M., Weinacker, A. B., … Bernstein, E. J. (2021). Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. -
Predicting PGD after Lung Transplantation
Diamond, J. M., Cantu, E., Oyster, M., Hsu, J., Localio, R., Shashaty, M., … Christie, J. (2021). Predicting PGD after Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 40(4), S156. -
Contemporary trends in PGD incidence, outcomes, and therapies.
Cantu, E., Diamond, J. M., Cevasco, M., Suzuki, Y., Crespo, M., Clausen, E., … Christie, J. D. (2022). Contemporary trends in PGD incidence, outcomes, and therapies. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. -
Dynamic changes in plasma ICAM and VWF levels in primary graft dysfunction after lung transplantation
Christie, J. D., Kawut, S., DeAndrade, J., Milstone, A., Weinacker, A., Orens, J., … Ware, L. (2006). Dynamic changes in plasma ICAM and VWF levels in primary graft dysfunction after lung transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Donor glutathione S-transferase genotype is associated with primary graft dysfunction following lung transplantation
Christie, J. D., Aplenc, R., DeAndrade, J., Kawut, S., Milstone, A., Weinacker, A., … Ely, E. W. (2005). Donor glutathione S-transferase genotype is associated with primary graft dysfunction following lung transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Upper extremity deep venous thrombosis in critically ill patients: Risk factors and outcomes
Lee, P., Weinacker, A., & Gould, M. (2004). Upper extremity deep venous thrombosis in critically ill patients: Risk factors and outcomes. CHEST. AMER COLL CHEST PHYSICIANS. -
Plasma Complement Levels Are Associated with Primary Graft Dysfunction and Mortality after Lung Transplantation
Shah, R. J., Emtiazjoo, A. M., Diamond, J. M., Smith, P. A., Roe, D. W., Wille, K. M., … Wilkes, D. S. (2014). Plasma Complement Levels Are Associated with Primary Graft Dysfunction and Mortality after Lung Transplantation. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 189(12), 1564–1567. -
Differential Effects Of Single And Bilateral Lung Transplantation On Serum Surfactant Protein D Levels In Subjects With Idiopathic Pulmonary Fibrosis
Sims, M., Beers, M. F., Ahya, V. N., Kawut, S. M., Lederer, D. J., Palmer, S. M., … Ware, L. B. (2010). Differential Effects Of Single And Bilateral Lung Transplantation On Serum Surfactant Protein D Levels In Subjects With Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC. -
Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated With High-Grade Primary Graft Dysfunction
Diamond, J. M., Ahya, V. N., Kawut, S. M., Lederer, D. J., Palmer, S. M., Crespo, M., … Ware, L. B. (2010). Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated With High-Grade Primary Graft Dysfunction. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC. -
Obesity Is Associated With An Increased Risk Of Primary Graft Dysfunction After Lung Transplantation: The LTOG Obesity Study
Winterbottom, C., Kawut, S. M., Ware, L. B., Bhorade, S., Palmer, S. M., Wille, K. M., … Lederer, D. J. (2010). Obesity Is Associated With An Increased Risk Of Primary Graft Dysfunction After Lung Transplantation: The LTOG Obesity Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC. -
Plasma Free Hemoglobin Potentiates the Association between Reperfusion FiO2 and Primary Graft Dysfunction after Lung Transplantation
Ware, L. B., Janz, D. R., Diamond, J. M., Lederer, D. J., Kawut, S. M., Bhorade, S., … Christie, J. D. (2013). Plasma Free Hemoglobin Potentiates the Association between Reperfusion FiO2 and Primary Graft Dysfunction after Lung Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
Higher Plasma Leptin Levels Are Associated with Primary Graft Dysfunction after Lung Transplantation: The LTOG Obesity Study
Lederer, D. J., Kawut, S. M., Wickersham, N., Winterbottom, C., Diamond, J., Bhorade, S., … Christie, J. D. (2011). Higher Plasma Leptin Levels Are Associated with Primary Graft Dysfunction after Lung Transplantation: The LTOG Obesity Study. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ELSEVIER SCIENCE INC. -
The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.
Diamond, J. M., Cantu, E., Calfee, C. S., Anderson, M. R., Clausen, E. S., Shashaty, M. G., … Christie, J. D. (2023). The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation. American Journal of Respiratory and Critical Care Medicine.
-
The patient's response to medical futility
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Chest Clinic in Palo Alto Stanford, CA
Stanford, CAChest Clinic in Palo Alto
300 Pasteur Dr, 1st Fl Rm A175
Stanford , CA 94305
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(20 reviews)
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records